Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

New uses of thalidomide

Article Abstract:

Preliminary reports on the effectiveness of thalidomide in the treatment of several disorders are encouraging, despite potentially serious side effects. After causing birth defects in Europe in the 1950's, thalidomide is now being investigated for treating erythema nodosum leprosum, AIDS complications, ulcers, skin inflammations, and organ rejection after transplantation. Thalidomide inhibits the development of blood vessels in the fetus, regulates the immune response, and has anti-inflammatory properties. Even small doses of thalidomide are associated with physical defects in the unborn. Irreversible peripheral nerve disorders, sedation, constipation, and rash are also common side effects. The AIDS Clinical Trials Information Service has details about current studies involving thalidomide.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1996
Complications and side effects, Immune response, Immune response regulation, Teratogenic agents, Erythema nodosum

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Thalidomide -- a revival story

Article Abstract:

Thalidomide may be beneficial for some patients with multiple myeloma. Multiple myeloma is a bone cancer that is very hard to treat. A 1999 study showed that 32% of 84 patients with multiple myeloma benefited from thalidomide treatment. Many had not responded to chemotherapy. It is not clear how thalidomide benefits myeloma patients. It is known to suppress the formation of new blood vessels, which tumors must do in order to spread to other parts of the body. Research has shown that patients with multiple myeloma have new blood vessel formation in their bone marrow. The drug may also inhibit myeloma cells directly.

Author: Raje, Noopur, Anderson, Kenneth
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
Editorial, Multiple myeloma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Thalidomide

Article Abstract:

The FDA has approved thalidomide for the treatment of leprosy. Although thalidomide was banned in the early 1960's when it was linked to severe birth defects, it has anti-inflammatory properties. It is effective in treating some types of ulcers, Behcet's disease, graft-versus-host disease, and some inflammatory skin diseases. Patients with rheumatoid arthritis, AIDS wasting syndrome, Kaposi's sarcoma, ulcerative colitis can also benefit from the drug. Caution is necessary when used because it has severe side effects in addition to its potential to cause birth defects.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1998
Evaluation, Leprosy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Drug therapy, Thalidomide
Similar abstracts:
  • Abstracts: A wait on my mind. The uncharted mind. Preying on your mind
  • Abstracts: New drugs from the rain forests. Think - before using drugs! Regulatory control and the rational use of drugs
  • Abstracts: Making sense of arterial blood gases and their interpretation. Making sense of the process and effects of ECT
  • Abstracts: School safety. Why do we manage health and safety?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.